image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates

Fusionex - Higher than anticipated GIANT win rate

June 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • FNX
  • Price:
  • 400p
Fusionex’s H1 results continue to show the group growing into its valuation. Quickly. Revenue for H1 to end March increased 26% to MYR 31.6m with adjusted ebitda up 36% to MYR 13.6m and pretax profits up 33% to MYR 10.8m. Eps were up from 17.5 to 29.3 SEN (5.1p).The period saw strong sales momentum for its Big Data Analytics product, GIANT, with 13 new customers, taking its total to 25. These comprised new as well as existing clients and GIANT’s revenue has more than doubled year-on-year to RM11.7m - representing 37% of the total sales. Notable names include Intel, AEON, TV3, Lotus Automobile, a Smart City and Brother Industries.Chief executive, Ivan Teh says that given GIANT contracts are sold on a rental basis and given the ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Fonix (February 2023)
Fonix (April 2022)
Fonix - Plans European expansion (March 2022)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW